Skip to main content
. 2023 Jan 2;24:1. doi: 10.1186/s12864-022-09103-5

Table 2.

Translocation breakpoint characteristics identified by MaReCs

Patient Cytogenetic results Number of embryos tested Breakpoint location
Patient 1 46,XX,t(2;5)(q14.2;p13.1) 11 chr2: 125,200,001 ± 200k; chr5: 35,500,001 ± 200k
Patient 2 46,XY,t(13;17)(q11;q11.2) 12 chr13: 26,200,001 ± 200k; chr17: 34,000,001 ± 200k